{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:31:57Z","timestamp":1790937117150,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1011387","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000}}],"reference-count":89,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK074731"],"award-info":[{"award-number":["R01-DK074731"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R56-DK074731"],"award-info":[{"award-number":["R56-DK074731"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R21-AG054903"],"award-info":[{"award-number":["R21-AG054903"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UH2\/3 AI-122320"],"award-info":[{"award-number":["UH2\/3 AI-122320"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>\n                    Infections caused by members of the mycobacterium tuberculosis complex [MTC] and nontuberculous mycobacteria [NTM] can induce widespread morbidity and mortality in people. Mycobacterial infections cause both a delayed immune response, which limits rate of bacterial clearance, and formation of granulomas, which contain bacterial spread, but also contribute to lung damage, fibrosis, and morbidity. Granulomas also limit access of antibiotics to bacteria, which may facilitate development of resistance. Bacteria resistant to some or all antibiotics cause significant morbidity and mortality, and newly developed antibiotics readily engender resistance, highlighting the need for new therapeutic approaches. Imatinib mesylate, a cancer drug used to treat chronic myelogenous leukemia [CML] that targets Abl and related tyrosine kinases, is a possible host-directed therapeutic [HDT] for mycobacterial infections, including those causing TB. Here, we use the murine\n                    <jats:italic>Mycobacterium marinum<\/jats:italic>\n                    [Mm] infection model, which induces granulomatous tail lesions. Based on histological measurements, imatinib reduces both lesion size and inflammation of surrounding tissue. Transcriptomic analysis of tail lesions indicates that imatinib induces gene signatures indicative of immune activation and regulation at early time points post infection that resemble those seen at later ones, suggesting that imatinib accelerates but does not substantially alter anti-mycobacterial immune responses. Imatinib likewise induces signatures associated with cell death and promotes survival of bone marrow-derived macrophages [BMDMs] in culture following infection with Mm. Notably, the capacity of imatinib to limit formation and growth of granulomas\n                    <jats:italic>in vivo<\/jats:italic>\n                    and to promote survival of BMDMs\n                    <jats:italic>in vitro<\/jats:italic>\n                    depends upon caspase 8, a key regulator of cell survival and death. These data provide evidence for the utility of imatinib as an HDT for mycobacterial infections in accelerating and regulating immune responses, and limiting pathology associated with granulomas, which may mitigate post-treatment morbidity.\n                  <\/jats:p>","DOI":"10.1371\/journal.ppat.1011387","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:58:13Z","timestamp":1684418293000},"page":"e1011387","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5141-2764","authenticated-orcid":true,"given":"Tesia L.","family":"Cleverley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Peddineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Guarner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cingolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela K.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S.","family":"Mocarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0693-2928","authenticated-orcid":true,"given":"Daniel","family":"Kalman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"ppat.1011387.ref001","article-title":"Tuberculosis","author":"WHO","year":"2021"},{"issue":"2","key":"ppat.1011387.ref002","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TNMI7-0038-2016","article-title":"Mycobacterium marinum.","volume":"5","author":"A Aubry","year":"2017","journal-title":"Microbiol Spectr"},{"issue":"1\u20132","key":"ppat.1011387.ref003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1574-6968.1994.tb07194.x","article-title":"Mycobacterial cell wall: structure and role in natural resistance to antibiotics","volume":"123","author":"V Jarlier","year":"1994","journal-title":"FEMS Microbiol Lett"},{"issue":"2","key":"ppat.1011387.ref004","article-title":"Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models","volume":"10","author":"S Saxena","year":"2021","journal-title":"Biology (Basel)."},{"issue":"2","key":"ppat.1011387.ref005","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.08-2427","article-title":"Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran","volume":"136","author":"AA Velayati","year":"2009","journal-title":"Chest"},{"issue":"4","key":"ppat.1011387.ref006","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cid\/cir889","article-title":"Totally drug-resistant tuberculosis in India","volume":"54","author":"ZF Udwadia","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"8","key":"ppat.1011387.ref007","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nmicrobiol.2016.78","article-title":"Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in Mycobacterium tuberculosis","volume":"1","author":"EJR Peterson","year":"2016","journal-title":"Nat Microbiol"},{"issue":"20","key":"ppat.1011387.ref008","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMc1505196","article-title":"Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis","volume":"373","author":"GV Bloemberg","year":"2015","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"ppat.1011387.ref009","first-page":"S55","article-title":"Novel therapies for treatment of resistant and refractory nontuberculous mycobacterial infections in patients with cystic fibrosis.","volume":"56","author":"TW Laudone","year":"2021","journal-title":"Pediatr Pulmonol."},{"key":"ppat.1011387.ref010","doi-asserted-by":"crossref","first-page":"919474","DOI":"10.1155\/2014\/919474","article-title":"Highlight on advances in nontuberculous mycobacterial disease in North America.","volume":"2014","author":"M Mirsaeidi","year":"2014","journal-title":"Biomed Res Int"},{"issue":"1","key":"ppat.1011387.ref011","doi-asserted-by":"crossref","first-page":"e16161","DOI":"10.1371\/journal.pone.0016161","article-title":"Profiling early lung immune responses in the mouse model of tuberculosis","volume":"6","author":"DD Kang","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"ppat.1011387.ref012","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.4049\/jimmunol.179.4.2509","article-title":"Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo","volume":"179","author":"AJ Wolf","year":"2007","journal-title":"J Immunol"},{"issue":"8","key":"ppat.1011387.ref013","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1462-5822.2009.01335.x","article-title":"Mycobacterial survival strategies in the phagosome: defence against host stresses","volume":"11","author":"S Ehrt","year":"2009","journal-title":"Cell Microbiol"},{"issue":"9","key":"ppat.1011387.ref014","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.20031072","article-title":"Mycobacterium marinum escapes from phagosomes and is propelled by actin-based motility","volume":"198","author":"LM Stamm","year":"2003","journal-title":"J Exp Med"},{"issue":"6","key":"ppat.1011387.ref015","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1365-2958.2004.04261.x","article-title":"A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion","volume":"53","author":"LY Gao","year":"2004","journal-title":"Mol Microbiol"},{"issue":"3","key":"ppat.1011387.ref016","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1083\/jcb.200205034","article-title":"Mycobacterium and the coat of many lipids","volume":"158","author":"DG Russell","year":"2002","journal-title":"J Cell Biol"},{"issue":"3 Pt 1","key":"ppat.1011387.ref017","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.134.3.713","article-title":"Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes","volume":"134","author":"JA Armstrong","year":"1971","journal-title":"J Exp Med"},{"issue":"8","key":"ppat.1011387.ref018","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1462-5822.2012.01799.x","article-title":"ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria","volume":"14","author":"D Houben","year":"2012","journal-title":"Cell Microbiol"},{"issue":"1","key":"ppat.1011387.ref019","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.20071367","article-title":"Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs","volume":"205","author":"AJ Wolf","year":"2008","journal-title":"J Exp Med"},{"issue":"7","key":"ppat.1011387.ref020","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1084\/jem.20052545","article-title":"Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection","volume":"203","author":"SA Khader","year":"2006","journal-title":"J Exp Med"},{"issue":"8","key":"ppat.1011387.ref021","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri3259","article-title":"The immunological life cycle of tuberculosis","volume":"12","author":"JD Ernst","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"ppat.1011387.ref022","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/IAI.70.8.4501-4509.2002","article-title":"Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity","volume":"70","author":"AA Chackerian","year":"2002","journal-title":"Infect Immun"},{"issue":"31","key":"ppat.1011387.ref023","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1073\/pnas.0801496105","article-title":"ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes","volume":"105","author":"WW Reiley","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3\u20134","key":"ppat.1011387.ref024","first-page":"311","article-title":"Some clinical features of tuberculosis. 1. Incubation period","volume":"24","author":"A. Poulsen","year":"1950","journal-title":"Acta Tuberc Scand."},{"issue":"11","key":"ppat.1011387.ref025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-3879(48)80033-4","article-title":"The time-table of tuberculosis","volume":"29","author":"A. Wallgren","year":"1948","journal-title":"Tubercle"},{"issue":"2","key":"ppat.1011387.ref026","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00611-19","article-title":"Dynamics of Mycobacterium tuberculosis Ag85B Revealed by a Sensitive Enzyme-Linked Immunosorbent Assay.","volume":"10","author":"JD Ernst","year":"2019","journal-title":"mBio"},{"key":"ppat.1011387.ref027","doi-asserted-by":"crossref","first-page":"l5770","DOI":"10.1136\/bmj.l5770","article-title":"Is Mycobacterium tuberculosis infection life long?","volume":"367","author":"MA Behr","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"ppat.1011387.ref028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/15.1.1","article-title":"Mycobacterial diseases other than tuberculosis","volume":"15","author":"E. Wolinsky","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ppat.1011387.ref029","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.4049\/jimmunol.162.6.3504","article-title":"Structural Deficiencies in Granuloma Formation in TNF Gene-Targeted Mice Underlie the Heightened Susceptibility to Aerosol Mycobacterium tuberculosis Infection, Which Is Not Compensated for by Lymphotoxin","volume":"162","author":"AGD Bean","year":"1999","journal-title":"The Journal of Immunology"},{"issue":"4","key":"ppat.1011387.ref030","first-page":"379","article-title":"Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice","volume":"79","author":"H Kaneko","year":"1999","journal-title":"Lab Invest"},{"issue":"15","key":"ppat.1011387.ref031","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"J Keane","year":"2001","journal-title":"N Engl J Med"},{"issue":"8","key":"ppat.1011387.ref032","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"JJ G\u00f3mez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"ppat.1011387.ref033","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1038\/s41598-022-07968-w","article-title":"TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area","volume":"12","author":"DW Park","year":"2022","journal-title":"Scientific Reports"},{"issue":"5","key":"ppat.1011387.ref034","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nri3211","article-title":"Revisiting the role of the granuloma in tuberculosis","volume":"12","author":"L. Ramakrishnan","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"ppat.1011387.ref035","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.immuni.2016.09.014","article-title":"Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and Promotes Infection","volume":"45","author":"MR Cronan","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"ppat.1011387.ref036","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tube.2006.11.003","article-title":"Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs","volume":"87","author":"RL Hunter","year":"2007","journal-title":"Tuberculosis (Edinb)."},{"issue":"3","key":"ppat.1011387.ref037","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/mi.2011.14","article-title":"Macrophages and control of granulomatous inflammation in tuberculosis","volume":"4","author":"JL Flynn","year":"2011","journal-title":"Mucosal Immunology"},{"issue":"147","key":"ppat.1011387.ref038","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology.","volume":"27","author":"S Ravimohan","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"3","key":"ppat.1011387.ref039","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00159-19","article-title":"Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters.","volume":"33","author":"JP Sarathy","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"ppat.1011387.ref040","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02266-17","article-title":"Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum","volume":"62","author":"JP Sarathy","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ppat.1011387.ref041","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/thorax.55.1.32","article-title":"Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment","volume":"55","author":"E Hnizdo","year":"2000","journal-title":"Thorax"},{"issue":"2","key":"ppat.1011387.ref042","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1183\/09031936.98.12020351","article-title":"Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis","volume":"12","author":"ML Plit","year":"1998","journal-title":"Eur Respir J"},{"issue":"3","key":"ppat.1011387.ref043","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/thoraxjnl-2019-213808","article-title":"Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study","volume":"75","author":"J Meghji","year":"2020","journal-title":"Thorax"},{"issue":"4","key":"ppat.1011387.ref044","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/thoraxjnl-2020-215338","article-title":"The long term effect of pulmonary tuberculosis on income and employment in a low income, urban setting.","volume":"76","author":"J Meghji","year":"2021","journal-title":"Thorax"},{"issue":"1","key":"ppat.1011387.ref045","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/imr.12255","article-title":"New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics","volume":"264","author":"TR Hawn","year":"2015","journal-title":"Immunol Rev"},{"issue":"5","key":"ppat.1011387.ref046","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2011.09.010","article-title":"Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis","volume":"10","author":"RJ Napier","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"8","key":"ppat.1011387.ref047","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.4049\/jimmunol.1201538","article-title":"Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophages","volume":"189","author":"H Bruns","year":"2012","journal-title":"J Immunol"},{"issue":"3","key":"ppat.1011387.ref048","doi-asserted-by":"crossref","first-page":"e1004770","DOI":"10.1371\/journal.ppat.1004770","article-title":"Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity","volume":"11","author":"RJ Napier","year":"2015","journal-title":"PLoS Pathog"},{"issue":"10","key":"ppat.1011387.ref049","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nm.4177","article-title":"Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure","volume":"22","author":"ST Malherbe","year":"2016","journal-title":"Nat Med"},{"key":"ppat.1011387.ref050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1748-717X-4-66","article-title":"Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model","volume":"4","author":"M Li","year":"2009","journal-title":"Radiat Oncol"},{"issue":"1","key":"ppat.1011387.ref051","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/art.24186","article-title":"Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis","volume":"60","author":"A Akhmetshina","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7","key":"ppat.1011387.ref052","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1096\/fj.07-105627","article-title":"Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis","volume":"22","author":"A Akhmetshina","year":"2008","journal-title":"Faseb j"},{"issue":"1","key":"ppat.1011387.ref053","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.22314","article-title":"Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis","volume":"56","author":"JH Distler","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"ppat.1011387.ref054","doi-asserted-by":"crossref","first-page":"G907","DOI":"10.1152\/ajpgi.00420.2004","article-title":"Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats.","volume":"288","author":"H Yoshiji","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"ppat.1011387.ref055","doi-asserted-by":"crossref","first-page":"F142","DOI":"10.1152\/ajprenal.00320.2009","article-title":"Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis","volume":"298","author":"S Wang","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2\u20133","key":"ppat.1011387.ref056","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1054\/tube.2002.0322","article-title":"TNF-dependent BALB\/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner","volume":"82","author":"J Keane","year":"2002","journal-title":"Tuberculosis (Edinb)."},{"issue":"12","key":"ppat.1011387.ref057","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1086\/593174","article-title":"Tumor Necrosis Factor Blockers Influence Macrophage Responses to Mycobacterium tuberculosis","volume":"198","author":"J Harris","year":"2008","journal-title":"The Journal of Infectious Diseases"},{"issue":"8","key":"ppat.1011387.ref058","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.141.8.2629","article-title":"Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis","volume":"141","author":"SM Laster","year":"1988","journal-title":"J Immunol"},{"key":"ppat.1011387.ref059","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fcell.2020.00365","article-title":"The Balance of TNF Mediated Pathways Regulates Inflammatory Cell Death Signaling in Healthy and Diseased Tissues.","volume":"8","author":"JD Webster","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"ppat.1011387.ref060","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.15252\/embr.201642592","article-title":"SPATA2 promotes CYLD activity and regulates TNF-induced NF-\u03baB signaling and cell death","volume":"17","author":"L Schlicher","year":"2016","journal-title":"EMBO Rep"},{"issue":"7784","key":"ppat.1011387.ref061","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","article-title":"Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis","volume":"575","author":"M Fritsch","year":"2019","journal-title":"Nature"},{"issue":"7784","key":"ppat.1011387.ref062","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-019-1752-8","article-title":"Activity of caspase-8 determines plasticity between cell death pathways","volume":"575","author":"K Newton","year":"2019","journal-title":"Nature"},{"issue":"11","key":"ppat.1011387.ref063","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrm3214","article-title":"It cuts both ways: reconciling the dual roles of caspase 8 in cell death and survival","volume":"12","author":"A Oberst","year":"2011","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"6","key":"ppat.1011387.ref064","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","article-title":"Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha","volume":"137","author":"S He","year":"2009","journal-title":"Cell"},{"key":"ppat.1011387.ref065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fcell.2019.00019","article-title":"Combined Knockout of RIPK3 and MLKL Reveals Unexpected Outcome in Tissue Injury and Inflammation.","volume":"7","author":"C Moerke","year":"2019","journal-title":"Front Cell Dev Biol"},{"issue":"7338","key":"ppat.1011387.ref066","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature09857","article-title":"RIP3 mediates the embryonic lethality of caspase-8-deficient mice","volume":"471","author":"WJ Kaiser","year":"2011","journal-title":"Nature"},{"key":"ppat.1011387.ref067","article-title":"Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during persistent infection","volume":"2023","author":"W Zheng","year":"2023","journal-title":"bioRxiv"},{"issue":"4","key":"ppat.1011387.ref068","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1128\/IAI.72.4.2400-2404.2004","article-title":"MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression","volume":"72","author":"CA Scanga","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"ppat.1011387.ref069","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.186.1.39","article-title":"Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis.","volume":"186","author":"AM Cooper","year":"1997","journal-title":"J Exp Med"},{"issue":"6","key":"ppat.1011387.ref070","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"AM Cooper","year":"1993","journal-title":"J Exp Med"},{"issue":"2","key":"ppat.1011387.ref071","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.immuni.2008.06.011","article-title":"Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death","volume":"29","author":"H Clay","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"ppat.1011387.ref072","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.27271","article-title":"Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model","volume":"62","author":"PL Lin","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3","key":"ppat.1011387.ref073","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2013.03.022","article-title":"TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species","volume":"153","author":"FJ Roca","year":"2013","journal-title":"Cell"},{"issue":"5","key":"ppat.1011387.ref074","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cell.2010.02.013","article-title":"The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans","volume":"140","author":"DM Tobin","year":"2010","journal-title":"Cell"},{"issue":"6","key":"ppat.1011387.ref075","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"JL Flynn","year":"1993","journal-title":"J Exp Med"},{"issue":"1","key":"ppat.1011387.ref076","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1073\/pnas.1711373114","article-title":"In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control of Mycobacterium tuberculosis","volume":"115","author":"US Gautam","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ppat.1011387.ref077","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41590-021-01121-x","article-title":"The immunoregulatory landscape of human tuberculosis granulomas","volume":"23","author":"EF McCaffrey","year":"2022","journal-title":"Nature Immunology"},{"issue":"2","key":"ppat.1011387.ref078","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: pathogenesis, etiology and regulation","volume":"2","author":"MS Wilson","year":"2009","journal-title":"Mucosal Immunology"},{"issue":"8","key":"ppat.1011387.ref079","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022459","article-title":"Interaction of Mycobacterium tuberculosis with host cell death pathways","volume":"4","author":"L Srinivasan","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7034","key":"ppat.1011387.ref080","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nature03419","article-title":"Ipr1 gene mediates innate immunity to tuberculosis","volume":"434","author":"H Pan","year":"2005","journal-title":"Nature"},{"issue":"9","key":"ppat.1011387.ref081","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrmicro2387","article-title":"Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?","volume":"8","author":"SM Behar","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"ppat.1011387.ref082","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2012.06.010","article-title":"Efferocytosis is an innate antibacterial mechanism","volume":"12","author":"CJ Martin","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"3","key":"ppat.1011387.ref083","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1084\/jem.20181776","article-title":"A major role for ferroptosis in Mycobacterium tuberculosis-induced cell death and tissue necrosis","volume":"216","author":"EP Amaral","year":"2019","journal-title":"J Exp Med"},{"issue":"1","key":"ppat.1011387.ref084","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/leu.2009.233","article-title":"Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells","volume":"24","author":"A Puissant","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"ppat.1011387.ref085","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1038\/cddis.2012.201","article-title":"TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1","volume":"4","author":"DM Moujalled","year":"2013","journal-title":"Cell Death Dis"},{"issue":"10","key":"ppat.1011387.ref086","doi-asserted-by":"crossref","first-page":"e1005910","DOI":"10.1371\/journal.ppat.1005910","article-title":"Activity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell Death.","volume":"12","author":"NH Philip","year":"2016","journal-title":"PLoS Pathog"},{"issue":"6","key":"ppat.1011387.ref087","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/mi.2017.12","article-title":"Bcl-x(L) mediates RIPK3-dependent necrosis in M. tuberculosis-infected macrophages","volume":"10","author":"X Zhao","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"4","key":"ppat.1011387.ref088","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/fmb.12.19","article-title":"Back to the future: host-targeted chemotherapeutics for drug-resistant TB.","volume":"7","author":"RJ Napier","year":"2012","journal-title":"Future Microbiol."},{"key":"ppat.1011387.ref089","article-title":"Host-directed immunotherapy of viral and bacterial infections: past, present and future","author":"Wallis RS","year":"2022","journal-title":"Nature Reviews Immunology"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1011387","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1011387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T05:26:05Z","timestamp":1702445165000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1011387"}},"subtitle":[],"editor":[{"given":"David M.","family":"Lewinsohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":89,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1011387","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.11.28.518230","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]}}}